# OnCo record signet-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/signet-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "signet-therapeutics" ;
  schema:name "Signet Therapeutics"@en ;
  schema:alternateName "希格生科"@en, "Signet Therapeutics (Shenzhen) Co., Ltd."@en ;
  schema:description "Signet Therapeutics is a Shenzhen company that uses lab-grown tumour models and AI to find new targeted cancer drugs. Its lead drug, SIGX1094, is aimed at diffuse gastric cancer and is in an early trial in Beijing."@en ;
  schema:url <https://onco.cc/companies/signet-therapeutics/>, <https://signettx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://signettx.com/>, <https://signettx.com/about/>, <https://clinicaltrials.gov/study/NCT06739291> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/organoids/>, <https://onco.cc/technologies/ai-drug-design/> .